1. Home
  2. AMSF vs EMBC Comparison

AMSF vs EMBC Comparison

Compare AMSF & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AMERISAFE Inc.

AMSF

AMERISAFE Inc.

HOLD

Current Price

$32.50

Market Cap

630.9M

Sector

Finance

ML Signal

HOLD

Logo Embecta Corp.

EMBC

Embecta Corp.

HOLD

Current Price

$9.42

Market Cap

521.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMSF
EMBC
Founded
1985
1924
Country
United States
United States
Employees
N/A
N/A
Industry
Accident &Health Insurance
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
630.9M
521.7M
IPO Year
1996
2021

Fundamental Metrics

Financial Performance
Metric
AMSF
EMBC
Price
$32.50
$9.42
Analyst Decision
Buy
Buy
Analyst Count
3
2
Target Price
$50.33
$18.50
AVG Volume (30 Days)
165.9K
724.2K
Earning Date
04-28-2026
05-08-2026
Dividend Yield
8.05%
6.77%
EPS Growth
N/A
20.90
EPS
2.47
0.74
Revenue
$317,252,000.00
N/A
Revenue This Year
$8.06
$1.17
Revenue Next Year
$6.34
N/A
P/E Ratio
$13.26
$12.01
Revenue Growth
2.66
N/A
52 Week Low
$32.00
$8.72
52 Week High
$53.27
$15.55

Technical Indicators

Market Signals
Indicator
AMSF
EMBC
Relative Strength Index (RSI) 32.00 44.16
Support Level $32.00 N/A
Resistance Level $39.25 $10.88
Average True Range (ATR) 0.92 0.33
MACD -0.05 0.01
Stochastic Oscillator 0.00 44.86

Price Performance

Historical Comparison
AMSF
EMBC

About AMSF AMERISAFE Inc.

AMERISAFE Inc is a specialty provider of workers' compensation insurance focused on small to mid-sized employers engaged in hazardous industries, principally construction, trucking, logging and lumber, agriculture, manufacturing, maritime, and telecommunications. The company generates a majority of its revenue in the form of premiums. The Company operates as a single reportable segment, Insurance Operations.

About EMBC Embecta Corp.

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

Share on Social Networks: